Clinical Trial Results: A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind study comparing oral ibrexafungerp versus fluconazole following IV echinocandin for invasive candidiasis including candidemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Invasive Candidiasis

Drugs mentioned

• Fluconazole (Fluconazole)
• Ibrexafungerp (ibrexafungerp)

Snippet

Sponsor: Scynexis, Inc. | Conditions: Candidiasis, Invasive, Candidemia | Phase 3 | Status: TERMINATED | Results posted: 2026-08-10